Skip to main content

Genco Shipping & Trading Limited Issues Open Letter to Shareholders Following Withdrawal by Diana Shipping Inc. of its Offer

Genco Board Provided Diana Clear Criteria for a Transaction Reflecting Fair Value and in the Best Interests of All Genco Shareholders  Genco Sets the Record Straight on Diana’s Misleading Characterization of the Negotiations and Genco’s Transaction Framework Genco Is Firing on All Cylinders with Increased and Compelling Dividends Projected for 2026 NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today issued an open letter to Genco shareholders following the announcement by Diana Shipping Inc. (“Diana”) that Diana has withdrawn its offer to acquire all outstanding Genco shares not already owned by Diana: Dear Genco Shareholders: We are reaching out today to...

Continue reading

47/2026・Trifork Group: Interim report for the quarter ending 30 June 2026

Schindellegi, Switzerland – 17 August 2026 Trifork Group AGCompany announcement no. 47/2026 Interim report for the quarter ending 30 June 2026 Trifork Group reports Q2 2026 adj. organic revenue growth of 11% and adj. EBITDA growth of 21% driven by a continued strong underlying execution in Products and robust performance in Services. The financial guidance for 2026 is reiterated. Comment from Group CEO Jørn Larsen“Q2 2026 was marked by solid execution. We delivered in line with expectations and remain on track for our full-year guidance. We also worked to release value from our Labs investments, announcing an attractive transaction with Verdane in July that is expected to generate additional capital returns to our shareholders. Strategically, we are determined to become a truly product-led company. In Q2, we added experienced product-focused...

Continue reading

Net asset value of the EfTEN United Property Fund as of 31.07.2026

EfTEN United Property Fund earned a net loss of 143 thousand euros in July, and a net profit of 566 thousand euros over the first seven months of 2026 (compared to 1 846 thousand euros net profit in the same period last year). The net asset value (NAV) of the fund unit was 11,56 euros at the end of July, decreasing by 0,6% over the month. The loss was primarily related to the corporate income tax paid on the Invego Uus-Järveküla OÜ dividend distribution. In July, one terraced-house was handed over to a client (a real right agreement was concluded) in Invego Uus-Järveküla OÜ, a development company in which the Fund holds an 80% stake, and the development company earned 46 thousand euros in pre-tax profit. Three terraced-houses and two land plots remain unsold in the development project. At the end of July and the beginning of August, the...

Continue reading

Nasdaq and Moomoo host inaugural Investor Day

SYDNEY, Aug. 17, 2026 (GLOBE NEWSWIRE) — Nasdaq is joining Moomoo Australia and New Zealand, operator of the moomoo platform, to host their first joint Investor Day in Sydney today. The event brings together global and local experts for panel discussions and workshops, featuring a keynote address from Nasdaq chief economist Phil Mackintosh. Mr Mackintosh will outline the macroeconomic forces shaping global sharemarkets, with a focus on the outlook for the artificial intelligence trade. He will be joined by leaders from Moomoo, CLSA, Rivkin Wealth Advisors and the Australian Shareholders’ Association to discuss building long-term wealth across Australian and international portfolios. Moomoo Australia and New Zealand chief executive officer Michael McCarthy said the event highlights the growing demand among local investors for institutional-quality...

Continue reading

Endeavour Silver Reports an Illegal Blockade and Suspension of Operations at its Terronera Mine

VANCOUVER, British Columbia, Aug. 16, 2026 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) reports that operations at its Terronera mine in Jalisco, Mexico have been temporarily suspended since August 12th as the result of an illegal blockade by members of the nearby Ejido community regarding their concerns over road maintenance, assistance with medical services and communications, control and access to water supply and increased financial assistance. To date, the blockade has remained peaceful, orderly and respectful. The site remains staffed with a reduced workforce to support safety and security protocols and continues to be accessible for maintenance activities. The Company continues active discussions with Ejido community leaders to resolve the matter and resume full operations...

Continue reading

Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

NEW YORK, Aug. 16, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has completed patient treatment in the MSB-DR004 pivotal randomized controlled Phase 3 trial of rexlemestrocel-L for chronic low back pain (CLBP) associated with the inflammatory condition of degenerative disc disease. The major milestone was achieved with 350 patients randomized and treated with either an intra-discal injection of rexlemestrocel-L or sham injection. Total patient numbers treated increased from 300 to 350 after strong demand from trial investigators to have their patients enrolled in the innovative program. The trial’s primary endpoint aims to confirm the durable pain reduction at 12 months from a single intra-discal injection of rexlemestrocel-L...

Continue reading

HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO®

— First global Phase III trial to show significant progression-free and overall survival benefits in this setting — — SAFFRON trial results reinforce TAGRISSO® as the backbone therapy across EGFRm lung cancer — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 17, 2026 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that positive high-level results from the SAFFRON Phase III trial showed ORPATHYS® (savolitinib) plus TAGRISSO® (osimertinib) demonstrated a statistically significant and clinically meaningful improvement in both progression-free survival (“PFS”) and overall survival (“OS”) versus doublet platinum-based chemotherapy in patients with epidermal growth factor receptor-mutated (“EGFRm”) non-small cell lung cancer (“NSCLC”). Patients in the trial had tumors with high levels...

Continue reading

Rocket Lab Satellite Platforms Built for MDA Space Successfully Reach Orbit, Supporting Globalstar Direct-to-Device Communications Services

Rocket Lab Lightning BusRocket Lab Satellite Platforms Built for MDA Space Successfully Reach Orbit, Supporting Globalstar Direct-to-Device Communications ServicesLONG BEACH, Calif., Aug. 16, 2026 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space systems, today announced the successful launch of eight advanced satellite platforms the Company built for MDA Space (TSX: MDA; NYSE: MDA), prime contractor for the replenishment of Globalstar’s (Nasdaq: GSAT) existing constellation, which provides direct-to-device communications services and IoT applications from orbit. The satellite platforms are the first batch in a constellation of 17 platforms Rocket Lab has built under a $143 million deal with MDA Space. The first eight of the 17 satellites were launched on Aug. 15 from...

Continue reading

Globalstar Confirms Successful Launch of All 8 HIBLEO-4 Replacement Satellites

Satellites launched aboard SpaceX Falcon 9 rocket reach orbital planeGlobalstar HIBLEO-4 LaunchGlobalstar confirms the successful launch of all 8 HIBLEO-4 replacement satellites aboard SpaceX Falcon 9 rocket.COVINGTON, La., Aug. 16, 2026 (GLOBE NEWSWIRE) — Globalstar (NASDAQ: GSAT), a next-generation telecommunications infrastructure and technology provider, today announced the successful launch and deployment of its latest satellites, marking another significant milestone in the continued expansion of the Company’s low Earth orbit (LEO) satellite constellation. Following a successful launch, all satellites were successfully dispensed from the launch vehicle and have reached their intended orbital planes. Globalstar’s Satellite Operations Command Center team has established communications with each satellite,...

Continue reading

HII’s Newport News Shipbuilding Completes Successful Acceptance Sea Trials of John F. Kennedy (CVN 79)

NEWPORT NEWS, Va., Aug. 15, 2026 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today that its Newport News Shipbuilding (NNS) division has successfully completed acceptance sea trials of John F. Kennedy (CVN 79), the second Gerald R. Ford-class nuclear-powered aircraft carrier. Kennedy returned to NNS after further testing and evaluation of important ship systems and components at sea. Earlier this year, Kennedy underwent successful builder’s sea trials. “It is an honor to take Kennedy to sea to demonstrate the quality work and commitment by our shipbuilders,” said Derek Murphy, NNS vice president of new construction aircraft carrier programs. “This critical set of sea trials is a testament to the entire nuclear shipbuilding enterprise and the work of thousands across our country to prepare CVN 79 to join the fleet.” The sea trials...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.